• AAPL 183.36
  • TSLA 181.14
  • AMZN 186.235
  • MSFT 406.8
  • INTC 30.9
  • EURUSD 1.0765
Overview Fundamentals API Earnings EOD API Sample Code Pricing
Register now
Free trial

No credit cards required

Get free API key
  1. Supported exchanges /
  2. IC /
  3. ALVO.IC

Alvotech (ALVO IC) stock market data APIs

kr2039.64 29.64(1.5%) as of May 3, 2024

Alvotech Financial Data Overview

2010.17
2039.64
-
2039.61
2009.75
890-2500
572 221 M
280 M
93 382 K
0.072
Our easy-to-use no-coding solutions help you get the data effortlessly:
Excel Financial Add-In Google Sheets Financial Add-In Python
APIs SDK Windows Downloader

No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.

General: {
Code: 'ALVO',
Type: 'Common Stock',
Name: 'Alvotech',
Exchange: 'IC',
CurrencyCode: 'ISK',
CurrencyName: 'Icelandik Krona',
CurrencySymbol: 'kr',
CountryName: 'Iceland',
CountryISO: 'IS',
OpenFigi: NULL,
ISIN: 'LU2458332611',
CIK: NULL,
EmployerIdNumber: NULL,
FiscalYearEnd: 'December',
IPODate: NULL,
InternationalDomestic: NULL,
Sector: 'Healthcare',
Industry: 'Drug Manufacturers - Specialty & Generic',
}

Alvotech Fundamental Data is available in our Financial Data APIs

  • Net Revenue 93 382 K
  • EBITDA -318 992 000
  • Earnings Per Share -345.92
  • Income Statements
  • Balance Sheets
  • Cash flows
Fundamental data package from $59.99 See full price
Get sample
of Fundamental API Data

Get Alvotech Earnings via APIs

  • Latest Release NaN
  • EPS/Forecast NaN

Get Alvotech End-of-day Data via APIs

  • End of Day, Intraday and Live APIs
  • Splits
  • Dividends

Get Alvotech latest news via APIs

Alvotech Announces Participation at BofA Securities Healthcare Conference 2024

Alvotech REYKJAVIK, Iceland, May 02, 2024 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients wo...

U.S. Commercialization Agreement with Quallent to Drive Patient Savings with First High-Concentration Citrate-Free Interchangeable Biosimilar to Humira® (adalimumab)

Alvotech Alvotech will manufacture its high-concentration interchangeable biosimilar to Humira® (adalimumab) for Quallent Pharmaceuticals The strategic agreement is in alignment with Alvotech’s U...
Do you have any questions?
support@eodhistoricaldata.com